Product Description
Falcigo 120mg Injection is administered as an injection by a healthcare professional. Kindly do not self-administer. It is given in cases where oral administration is not possible.
Some people may experience a headache, dizziness, weakness, and loss of appetite, as the side effects of this medicine. You may also notice some injection site reactions like pain, swelling, or redness. Please consult your doctor if these side effects persist for a longer duration. You may be monitored with blood tests once a week for 4 weeks to detect the presence of malarial parasites.
Highly Effective Against Severe MalariaFalcigo 120 MG is specifically recommended for adults and children facing severe malaria, a life-threatening disease. Its fast-acting Artesunate formulation rapidly reduces parasite levels in the blood, offering an effective and reliable option during critical medical situations. Consistent and proper administration under clinical supervision ensures optimal outcomes.
Easy-to-Use Combo PackFalcigo comes as a convenient vial and ampoule combo pack containing an injection vial with 120 mg Artesunate and a pre-measured ampoule of sterile solvent. This arrangement allows precise reconstitution and easier handling for healthcare professionals, ensuring accurate dosage and minimizing preparation errors.
Safe Storage and Long Shelf LifeThe product boasts a 24-month shelf life when stored below 25C, away from light and moisture. Its robust, allopathic formulation provides stability, while clear packaging instructions guarantee correct preservation, maintaining efficacy until the end of its shelf life.
FAQ's of Falcigo 120 MG:
Q: How is Falcigo 120 MG administered?
A: Falcigo 120 MG is administered either intravenously (IV) or intramuscularly (IM), only by qualified healthcare providers. The medication must be reconstituted using the provided sterile solvent ampoule before injection.
Q: What is the primary use of Falcigo 120 MG?
A: Falcigo 120 MG is used for the treatment of severe malaria in both adults and children. It is indicated for cases where prompt, potent antimalarial intervention is required, and is not for mild or uncomplicated malaria.
Q: When should Falcigo 120 MG not be used?
A: Falcigo 120 MG should not be used in individuals who have a known hypersensitivity to Artesunate or any component of the formulation. Always inform your physician about any allergies before starting treatment.
Q: Where should Falcigo 120 MG be stored for best efficacy?
A: The product must be stored below 25C, protected from light and moisture. Proper storage helps maintain the potency and safety of the injection throughout its 24-month shelf life.
Q: What are the steps in preparing Falcigo 120 MG for administration?
A: Healthcare professionals should reconstitute the Artesunate powder from the vial using the included sterile solvent ampoule. The solution is then administered intravenously or intramuscularly as prescribed by the doctor.
Q: Who is suitable for treatment with Falcigo 120 MG?
A: Both adults and children diagnosed with severe malaria are suitable candidates, provided they do not have hypersensitivity to Artesunate. Dosage and duration are determined by the physician.
Q: What are the benefits of using Falcigo 120 MG combo pack?
A: The combo pack ensures accurate medication preparation by providing both the Artesunate vial and the correct volume of sterile solvent. This minimizes errors and facilitates quick, efficient treatment in urgent medical scenarios.